Skip to main content
. 2015 Aug 28;5:13573. doi: 10.1038/srep13573

Figure 3. Alternations of activation of ERK1/2 and Akt in the PFC of CMS mice at 2 days post ketamine and Yueju administration.

Figure 3

(A) Densitometric analysis of phosphorylated Akt normalized to total Akt, ANOVA, F(3,20) = 4.042, p < 0.05. and (B) phosphorylated ERK1/2 normalized to total ERK1/2, ANOVA, F(3,20) = 1.443, p < 0.05. *p < 0.05, **p < 0.01, compared with control group. #p < 0.05, ##p < 0.01, compared with vehicle group, and n = 5−7.

HHS Vulnerability Disclosure